A new push for federal cannabis legalization has appeared in the form of a campaign, “Cannabis in Common,” launched Tuesday by a coalition of cannabis advocates, large marijuana businesses and celebrities like Seth Rogan and Sarah Silverman.
The idea behind the initiative, which is being backed by cannabis giants like Canopy Growth (NASDAQ: CGC), Curaleaf Holdings (OTCQX: CURLF) and Cronos Group (NASDAQ: CRON), is to encourage voters to reach out to Congress members and demand action on federal cannabis legalization, reported The Associated Press.
Silverman added, “Americans can’t agree on anything can we? Fortunately, there is at least one thing most Americans have in common: more than two-thirds of us agree cannabis should be legalized and we have a real shot at getting federal legalization done now if we speak up."
Through the launch of the website, cannabis advocates can more conveniently email or call their congressional representatives to insist on marijuana legalization.
As for cannabis companies, they also have a few tasks to undertake: emailing their customers, displaying posters in stores, and providing needed information through their apps to get more consumers to become part of the fight for nationwide legal pot.
"Cannabis legalization is an issue with the power to mobilize large numbers of voters, including many who are often disengaged from the political process. By partnering with cannabis-friendly celebrities and cannabis brands, we’re hoping to get a critical mass of legalization supporters to make their voices heard. It's clear that politicians are way behind voters on this issue. Cannabis in Common aims to change that,” said Sam D'Arcangelo, Director of HeadCount's Cannabis Voter Project, one of the organizations behind the initiative.
Steven Hawkins, CEO of US Cannabis Council, added, "We couldn't be happier with the launch of Cannabis In Common. There's broad alignment among our members and supporters to aggressively push Congress on legalization and expungement. With help from a growing cast of celebrities, cannabis businesses and advocacy organizations, we are poised to reach millions of voters and finally move the needle on cannabis in Washington."
What's Up In DC?
Just this week, Republicans released their marijuana legalization proposal led by Rep. Nancy Mace (R-SC). The measure, titled the States Reform Act, is currently in a preliminary form although a final version is expected to be filed later in November.
Some cannabis advocates see the new legalization push as a smart move because many don’t believe the Democrats’ far-reaching bill stands a chance of passing every chamber before being sent to President Joe Biden to sign.
While the new proposal is more modest than that of the Democrats, possibly making it more passable, the big question remains: Will President Biden change his stance? So far, the President opposes federal legalization of marijuana, supporting only decriminalization, legalizing medical use and leaving everything else up to states.
So far, eighteen states have legalized recreational marijuana and as many as 37 states now have legal medical marijuana programs.
How do cannabis advocates feel about “Cannabis in Common?”
It seems that opinions are divided on the initiative, which does not focus on any particular legalization proposal. While many nonprofit, pro-legalization groups support the new initiative, at least one points out some of its shortcomings.
The Drug Policy Alliance (DPA), calls the campaign “overly corporate and not dedicated enough to expunging past marijuana convictions and helping communities and people who have borne the brunt of pot arrests,” writes The Associated Press.
"For us, it's not just about getting federal legalization over the finish line," Maritza Perez of the DPA said. "We have a very specific constituency that we are fighting for, and that's people who have been impacted by prohibition."
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Missed the first wave of cannabis investments? Don’t make that mistake again.
Experts believe cannabis stocks have found their floor and are now poised for unprecedented growth.
Join Benzinga PotProfits. Our in-house canna stock expert, Michael Berger, is on a mission to uncover the most promising cannabis stocks poised for growth, even in a dull market. He leaves no bud unturned to bring you the juiciest potential double-digit opportunities!
Just this year, the PotProfits portfolio has seen smoking-hot gains like:
- 47.10% with $GTBIF
- 40.23% with $TCNNF
- 21.50% with $VFF